News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
91 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21807)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (1997)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (174)
7 (76)
9 (47)
10 (146)
11 (152)
12 (92)
13 (139)
14 (94)
16 (32)
17 (75)
18 (119)
19 (87)
20 (105)
21 (26)
23 (16)
24 (91)
25 (9)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
9
10
11
12
13
14
16
17
18
19
20
21
23
24
25
Press Releases
Avenzo Therapeutics Announces Appointment of Connie Wedel as Chief Human Resources Officer
August 24, 2026
·
5 min read
Press Releases
Copia Scientific Announces Distribution Agreement with HSE•AG to Expand Automated, On-Deck Nucleic Acid Quantification Solutions in North America
August 24, 2026
·
5 min read
FDA
REGENXBIO’s Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five patients enrolled in REGENXBIO’s registrational trial. The biotech no longer plans to resubmit the candidate—which was rejected in February—in the near term.
August 24, 2026
·
2 min read
·
Heather McKenzie
Press Releases
Novo Nordisk A/S - share repurchase programme - August 24, 2026
August 24, 2026
·
2 min read
Press Releases
Amplifica Appoints Hans Hofland, Ph.D., as Chief Development Officer and William Humphries to Board of Directors
August 24, 2026
·
4 min read
Press Releases
Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
August 24, 2026
·
1 min read
Press Releases
Phoenix Children’s Names Jamie Wiggins Executive Vice President, Chief Operating Officer and Chief Nursing Executive
August 24, 2026
·
3 min read
Press Releases
Galderma opens new U.S. and Latin America headquarters in Miami
August 24, 2026
·
5 min read
Press Releases
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
August 24, 2026
·
8 min read
Press Releases
R3 Vascular Expands Management Team with Two Senior Executives
August 24, 2026
·
4 min read
Previous
7 of 10
Next
